Rom E. Eliaz
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- biodegradable polymer synthesis and properties
Papers in
-
- Advanced Drug Delivery Systems 4
-
- Hydrogels: synthesis, properties, applications 3
- Co-authors
- Francis C. Szoka (4 shared papers)Joseph Kost (5 shared papers)Shlomo Nir (2 shared papers)Cornelia Marty (1 shared paper)David S. Wallach (1 shared paper)Eli Eyal (3 shared papers)Victor Abler (2 shared papers)David Wallach (1 shared paper)
- Journals
- Gene Therapy (1 paper)Journal of Biomedical Materials Research (1 paper)Pharmaceutical Research (1 paper)Methods in enzymology on CD-ROM/Methods in enzymology (1 paper)Drug and Alcohol Dependence (1 paper)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Rom E. Eliaz
12 papers receiving 814 citations
Peers
Comparison fields: 5 of 68
- Pharmaceutical Science 198
- Biomaterials 336
- Molecular Medicine 122
- Cell Biology 63
- Neurology 57
Countries citing papers authored by Rom E. Eliaz
This map shows the geographic impact of Rom E. Eliaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rom E. Eliaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rom E. Eliaz more than expected).
Fields of papers citing papers by Rom E. Eliaz
This network shows the impact of papers produced by Rom E. Eliaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rom E. Eliaz. The network helps show where Rom E. Eliaz may publish in the future.
Co-authors
The 25 scholars most cited alongside Rom E. Eliaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. | 2001 | 314 |
| 2 | 2000 | 150 | |
| 3 | 2004 | 133 | |
| 4 | 2016 | 54 | |
| 5 | 2000 | 46 | |
| 6 | 2002 | 46 | |
| 7 | 2016 | 35 | |
| 8 | 2004 | 30 | |
| 9 | 2016 | 20 | |
| 10 | 1996 | 19 | |
| 11 | 1998 | 9 | |
| 12 | 2005 | 1 |
About Rom E. Eliaz
Rom E. Eliaz is a scholar working on Pharmaceutical Science, Molecular Medicine, Biomaterials, Neurology and Pharmacology, having authored 12 papers that have together received 857 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Hydrogels: synthesis, properties, applications (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), RNA Interference and Gene Delivery (1 paper), Burn Injury Management and Outcomes (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Pharmaceutical Science (198 citations), Biomaterials (336 citations), Molecular Medicine (122 citations), Cell Biology (63 citations) and Neurology (57 citations). Rom E. Eliaz has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Francis C. Szoka, Joseph Kost, Shlomo Nir, Cornelia Marty, David S. Wallach, Eli Eyal, Victor Abler, David Wallach, Robert A. Hauser and Orit Cohen‐Barak. Their work appears in journals such as Gene Therapy, Journal of Biomedical Materials Research, Pharmaceutical Research, Methods in enzymology on CD-ROM/Methods in enzymology and Drug and Alcohol Dependence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.